US Restaurants "How Are GLP-1 Drugs Impacting Restaurant Demand?" Geiger

研报英文原文证据摘录

US Restaurants "How Are GLP-1 Drugs Impacting Restaurant Demand?" Geiger

Powered by Lab Global25 MayResearch2026ab Evidence UBS YES

US Restaurants Equities

AmericasHow Are GLP-1 Drugs Impacting Restaurant

Demand? Restaurants

Dennis Geiger, CFA

Analyst

dennis.geiger@ubs.com

Examining the impact of GLP-1 usage on restaurant industry demand +1-212-713 9313

We examined the latest UBS Evidence Lab US GLP-1 survey ( > Access Dataset ) to gauge Michael Yee

the potential impact from growing GLP-1 drug usage on the restaurant industry. Our Analyst

survey results suggest GLP-1 users are more likely to eat less calories while taking GLP-1 michael.yee@ubs.com

drugs, with survey respondents dining out less, changing eating habits, and appreciating +1-305-536 9101

healthier foods more. While still in the early stages, we believe increasing usage of GLP-1 Paul Hao

drugs could represent a sales headwind for many restaurant brands, including QSRs and Associate Analyst

those that are considered less healthy. Changes in eating behavior could also increase paul.hao@ubs.com

menu shifts towards healthier and smaller-portioned menu options. GLP-1 +1-201-352 1091

advancements over the coming years (incl oral pill format, fewer side effects, lower Nikhil Gunderia

prices) should support accessibility to GLP-1 drug use & increased adoption. Our current Associate Analyst

view is that GLP-1 drugs have had a modest impact on restaurant traffic and sales thus nikhil.gunderia@ubs.com

far, but with greater adoption we believe impacts will increase over time. +1-212-713 3258

Emily Li

How are GLP-1 drugs changing consumer eating habits? Associate Analyst

Our UBS Evidence Lab survey results suggest ~55% of respondents have changed their emily.li@ubs.com